Orion Oyj (HEL:ORNBV)
Finland
· Delayed Price · Currency is EUR 63.35
+0.80 (1.28%)
Jun 27, 2025, 6:29 PM EET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
Other Revenue seg1 | -100.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue seg1 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sale of Goods | 1.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sale of Goods Growth | 10.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Royalty Income | 292.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Royalty Income Growth | 122.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Milestone Payments | 132.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Milestone Payments Growth | 289.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Animal Health | 131.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Animal Health Growth | 20.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue seg2 | 200.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue seg2 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fermion | 67.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fermion Growth | -9.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Translation Differences and Other Operations | 300.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Translation Differences and Other Operations Growth | 0% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Innovative Medicines | 565.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Innovative Medicines Growth | 125.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Branded Products | 294.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Branded Products Growth | 8.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Generics and Consumer Health | 529.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Generics and Consumer Health Growth | 2.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
Finland | 349.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Finland Growth | 3.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Scandinavia | 168.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Scandinavia Growth | 13.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Europe | 440.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Europe Growth | 20.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America | 376.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | 101.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Markets | 253.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Markets Growth | 40.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
Human Pharmaceuticals (Hospital and Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Reference Priced Prescription Drugs (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-Care Products (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Prescription Drugs (Pharmacy Channel) Reported Market Share |
Log In |
Log In |
Log In |
Log In | Upgrade
|